Zydus Lifesciences

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue4,1394,1794,2965,0485,176
Expenses3,4553,5363,5163,9613,832
EBITDA898.90859.70994.501,2931,541
EBIT715.30677.90812.90513.501,347
Profit Before Tax672.70648.30780.50483.601,328
Net Profit554.30511.30585.30346.401,112
Financial Ratios
Earning Per Share (Diluted)5.065.156.152.9310.74
Dividends Per Share0.000.000.000.000.00
Operating Profit Margin22.63%21.94%23.92%23.35%30.20%
Net Profit Margin13.48%13.11%14.96%14.07%21.68%
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ